GB9403922D0 - Sustained release compositions - Google Patents

Sustained release compositions

Info

Publication number
GB9403922D0
GB9403922D0 GB9403922A GB9403922A GB9403922D0 GB 9403922 D0 GB9403922 D0 GB 9403922D0 GB 9403922 A GB9403922 A GB 9403922A GB 9403922 A GB9403922 A GB 9403922A GB 9403922 D0 GB9403922 D0 GB 9403922D0
Authority
GB
United Kingdom
Prior art keywords
sustained release
release compositions
compositions
sustained
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9403922A
Other versions
GB2288117A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to GB9403922A priority Critical patent/GB2288117A/en
Publication of GB9403922D0 publication Critical patent/GB9403922D0/en
Priority to IL10994494A priority patent/IL109944A/en
Priority to ES94304144T priority patent/ES2124372T5/en
Priority to AT94304144T priority patent/ATE172376T1/en
Priority to DE69414046T priority patent/DE69414046T3/en
Priority to EP94304144A priority patent/EP0636370B2/en
Priority to DK94304144T priority patent/DK0636370T4/en
Priority to SG1996009186A priority patent/SG50706A1/en
Priority to SK763-94A priority patent/SK280534B6/en
Priority to CZ19941550A priority patent/CZ287918B6/en
Priority to NO942470A priority patent/NO306449B1/en
Priority to FI943141A priority patent/FI114285B/en
Priority to PL94304062A priority patent/PL179282B1/en
Priority to AU66105/94A priority patent/AU6610594A/en
Priority to CA002127166A priority patent/CA2127166C/en
Priority to JP15121994A priority patent/JP3647897B2/en
Priority to KR1019940015740A priority patent/KR100365572B1/en
Priority to HU9402007A priority patent/HU220075B/en
Priority to BG99077A priority patent/BG62316B1/en
Priority to EG61694A priority patent/EG20600A/en
Priority to DK94308493T priority patent/DK0654263T3/en
Priority to PT94308493T priority patent/PT654263E/en
Priority to DE69429710T priority patent/DE69429710T2/en
Priority to AT94308493T priority patent/ATE212224T1/en
Priority to ES94308493T priority patent/ES2168290T3/en
Priority to EP94308493A priority patent/EP0654263B1/en
Priority to NZ264953A priority patent/NZ264953A/en
Priority to CZ19942866A priority patent/CZ289650B6/en
Priority to BG99198A priority patent/BG62429B1/en
Priority to IL11170994A priority patent/IL111709A/en
Priority to SK1406-94A priority patent/SK280496B6/en
Priority to EG74294A priority patent/EG20910A/en
Priority to FI945476A priority patent/FI113335B/en
Priority to HU9403353A priority patent/HU217205B/en
Priority to NO19944473A priority patent/NO314124B1/en
Priority to CN94118503A priority patent/CN1121213C/en
Priority to KR1019940031398A priority patent/KR100354702B1/en
Priority to AU79015/94A priority patent/AU682223C/en
Priority to JP28993694A priority patent/JP3411114B2/en
Publication of GB2288117A publication Critical patent/GB2288117A/en
Priority to US08/607,851 priority patent/US5891471A/en
Priority to US08/607,852 priority patent/US5849240A/en
Priority to US08/843,571 priority patent/US5879705A/en
Priority to US08/944,106 priority patent/US5965163A/en
Priority to AU52995/98A priority patent/AU722358B2/en
Priority to US09/264,399 priority patent/US6143328A/en
Priority to US09/370,270 priority patent/US6162467A/en
Priority to US09/740,732 priority patent/US20010019725A1/en
Priority to JP2002271157A priority patent/JP2003113075A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB9403922A 1991-12-24 1994-03-01 Sustained release morphine Withdrawn GB2288117A (en)

Priority Applications (48)

Application Number Priority Date Filing Date Title
GB9403922A GB2288117A (en) 1994-03-01 1994-03-01 Sustained release morphine
IL10994494A IL109944A (en) 1993-07-01 1994-06-08 Sustained release dosage unit forms containing morphine and a method of preparing these sustained release dosage unit forms
ES94304144T ES2124372T5 (en) 1993-07-01 1994-06-09 SUSTAINED RELEASE COMPOSITIONS CONTAINING MORPHINE.
AT94304144T ATE172376T1 (en) 1993-07-01 1994-06-09 MORPHINE-CONTAINING MEDICINAL COMPOSITIONS WITH DELAYED RELEASE
DE69414046T DE69414046T3 (en) 1993-07-01 1994-06-09 Morphine-containing medicinal compositions with delayed drug delivery
EP94304144A EP0636370B2 (en) 1993-07-01 1994-06-09 Sustained release compositions containing morphine
DK94304144T DK0636370T4 (en) 1993-07-01 1994-06-09 Deposits containing morphine
SG1996009186A SG50706A1 (en) 1993-07-01 1994-06-09 Sustained release compositions and a method of preparing pharmaceutical compositions
SK763-94A SK280534B6 (en) 1993-07-01 1994-06-23 Sustained release preparations of morphine and a method of preparing the same
CZ19941550A CZ287918B6 (en) 1993-07-01 1994-06-23 Orally administered unit dosage form with controlled release and process for preparing thereof
NO942470A NO306449B1 (en) 1993-07-01 1994-06-30 Orally administered morphine preparation for sustained release as well as preparation of multiparticulates for use in the preparation
FI943141A FI114285B (en) 1993-07-01 1994-06-30 Process for preparing sustained release pharmaceutical dosage unit form
PL94304062A PL179282B1 (en) 1993-07-01 1994-06-30 Retarded release compositions and method of obtaining such compositions
AU66105/94A AU6610594A (en) 1991-12-24 1994-06-30 Sustained release compositions and a method of preparing pharmaceutical compositions
CA002127166A CA2127166C (en) 1993-07-01 1994-06-30 Sustained release morphine compositions and a method of preparation
JP15121994A JP3647897B2 (en) 1993-07-01 1994-07-01 Sustained release unit dosage form
KR1019940015740A KR100365572B1 (en) 1993-07-01 1994-07-01 Sustained-release and pharmaceutical compositions
HU9402007A HU220075B (en) 1993-07-01 1994-07-01 Retarde pharmaceutical compositions containing morphine and process for producing them
BG99077A BG62316B1 (en) 1993-10-07 1994-09-29 Pharmaceutical forms with continuous release and method for their preparation
EG61694A EG20600A (en) 1993-10-07 1994-10-03 Sustained release compositions and a method of preparing pharmaceutical compositions
DK94308493T DK0654263T3 (en) 1993-11-23 1994-11-17 Process for the preparation of a sustained release preparation
PT94308493T PT654263E (en) 1993-11-23 1994-11-17 METHOD FOR THE PREPARATION OF A PROLONGED LIBERTYACAO COMPOSITION
DE69429710T DE69429710T2 (en) 1993-11-23 1994-11-17 Process for the preparation of a drug composition with delayed drug delivery
AT94308493T ATE212224T1 (en) 1993-11-23 1994-11-17 METHOD FOR PRODUCING A MEDICINAL COMPOSITION WITH DELAYED RELEASE
ES94308493T ES2168290T3 (en) 1993-11-23 1994-11-17 METHOD FOR PREPARING A SUSTAINED RELEASE COMPOSITION.
EP94308493A EP0654263B1 (en) 1993-11-23 1994-11-17 Method for preparing a sustained release composition
NZ264953A NZ264953A (en) 1993-11-23 1994-11-18 Manufacture of drug-containing particles from a mixture of particulate drug and a particulate hydrophobic and/or hydrophilic fusible carrier or diluent in a high speed mixer such that the carrier/diluent melts and breaking up the agglomerates thus formed; sustained release forms
CZ19942866A CZ289650B6 (en) 1993-11-23 1994-11-21 Process for preparing a medicament controllably releasing active substance thereof
BG99198A BG62429B1 (en) 1993-11-23 1994-11-21 Method for the preparation of pharmaceutical compositions
IL11170994A IL111709A (en) 1993-11-23 1994-11-21 Process for the manufacture of sustained release particles and dosage forms comprising particles obtained by the process
SK1406-94A SK280496B6 (en) 1993-11-23 1994-11-22 Process for preparing particles with permanent release of active substance
EG74294A EG20910A (en) 1993-11-23 1994-11-22 Sustained release compositions and a method of preparing pharmaceutical compositions
FI945476A FI113335B (en) 1993-11-23 1994-11-22 Process for the preparation of particles useful in pharmaceutical compositions
HU9403353A HU217205B (en) 1993-11-23 1994-11-22 Sustained release compositions and a method of preparing pharmaceutical compositions
NO19944473A NO314124B1 (en) 1993-11-23 1994-11-22 Process for the preparation of particles
CN94118503A CN1121213C (en) 1993-11-23 1994-11-23 Sustained release compositions and a method of preparing pharmaceutical compositions
KR1019940031398A KR100354702B1 (en) 1993-11-23 1994-11-23 Manufacturing method and sustained release composition of pharmaceutical composition
AU79015/94A AU682223C (en) 1993-11-23 1994-11-23 Sustained release compositions and a method of preparing pharmaceutical compositions
JP28993694A JP3411114B2 (en) 1993-11-23 1994-11-24 Method for producing long-acting composition and pharmaceutical composition
US08/607,851 US5891471A (en) 1993-11-23 1996-02-27 Pharmaceutical multiparticulates
US08/607,852 US5849240A (en) 1993-11-23 1996-02-27 Method of preparing sustained release pharmaceutical compositions
US08/843,571 US5879705A (en) 1993-07-27 1997-04-18 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US08/944,106 US5965163A (en) 1993-11-23 1997-09-30 Substained release compositions and a method of preparing pharmaceutical compositions
AU52995/98A AU722358B2 (en) 1991-12-24 1998-02-06 Sustained release compositions and a method of preparing pharmaceutical compositions
US09/264,399 US6143328A (en) 1993-07-27 1999-03-08 Sustained release compositions and a method of preparing pharmaceutical compositions
US09/370,270 US6162467A (en) 1993-11-23 1999-08-09 Sustained release compositions and a method of preparing pharmaceutical compositions
US09/740,732 US20010019725A1 (en) 1993-11-23 2000-12-19 Sustained release compositions and a method of preparing pharmaceutical compositions
JP2002271157A JP2003113075A (en) 1993-11-23 2002-09-18 Sustained release composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9403922A GB2288117A (en) 1994-03-01 1994-03-01 Sustained release morphine

Publications (2)

Publication Number Publication Date
GB9403922D0 true GB9403922D0 (en) 1994-04-20
GB2288117A GB2288117A (en) 1995-10-11

Family

ID=10751094

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9403922A Withdrawn GB2288117A (en) 1991-12-24 1994-03-01 Sustained release morphine

Country Status (1)

Country Link
GB (1) GB2288117A (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
WO1992001446A1 (en) * 1990-07-20 1992-02-06 Aps Research Limited Sustained-release formulations
NL9102142A (en) * 1991-12-20 1993-07-16 Dagra Pharma Bv Suppositories with delayed release and process for their preparation.
SE9202250D0 (en) * 1992-07-29 1992-07-29 Gacell Lab Ab CONTROLLED RELEASE MORPHINE PREPARATION

Also Published As

Publication number Publication date
GB2288117A (en) 1995-10-11

Similar Documents

Publication Publication Date Title
SG71879A1 (en) Controlled release compositions
HUP9903759A3 (en) Abtimicrobial compositions
ZA957233B (en) Topically-effective compositions
EG20929A (en) Cleasing compositions
GB9408545D0 (en) Compositions
GB9726814D0 (en) Compositions
SG71789A1 (en) Controlled release compositions
GB9702238D0 (en) Compositions
IL130856A0 (en) Peroxetine compositions
ZA975703B (en) Sustained release sufentanil compositions
GB9409543D0 (en) Compositions
GB9502770D0 (en) Amine-curable compositions
GB9315467D0 (en) Sustained release compositions
ZA954709B (en) Mineral-fiber compositions
GB2290299B (en) Anti-lubricant compositions
GB9724838D0 (en) Compositions
GB9416768D0 (en) Compositions
EP0705632A3 (en) 2-Methylpropenyl-terminated polyisobutylene-polydimethyl-siloxane compositions
GB9705340D0 (en) Compositions
GB9703109D0 (en) Compositions
GB9416767D0 (en) Compositions
GB9403922D0 (en) Sustained release compositions
GB2342044B (en) Quick release compositions
GB9712981D0 (en) Compositions
GB2336368B (en) Compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)